The Novartis Venture Fund started life in 1996 after the merger of Ciba and Sandoz. It was originally conceived only as a temporary instrument, but its focus on biotech became successful and gave the fund longevity. “With a mixture of luck and knowledge, we had success from investing in a ...
Please Login to read the full article.
